VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
VHI gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
VHI had a positive operating cash flow in the past year.
In multiple years VHI reported negative net income over the last 5 years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VHI's Return On Assets of 1.16% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Return On Equity of 1.58% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
The Return On Invested Capital of VHI (3.04%) is better than 100.00% of its industry peers.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 3.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROIC | 3.04% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI's Profit Margin of 3.79% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin of 11.73% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
VHI's Gross Margin of 80.86% is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VHI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VHI has been increased compared to 5 years ago.
The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
VHI has an Altman-Z score of 7.80. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VHI (7.80) is better than 75.00% of its industry peers.
The Debt to FCF ratio of VHI is 0.05, which is an excellent value as it means it would take VHI, only 0.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VHI (0.05) is better than 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 7.8 |
ROIC/WACC0.33
WACC9.14%
2.3 Liquidity
VHI has a Current Ratio of 2.35. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
VHI has a Current ratio of 2.35. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
A Quick Ratio of 2.34 indicates that VHI has no problem at all paying its short term obligations.
The Quick ratio of VHI (2.34) is better than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -53.85% in the last year.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 35.97%.
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 82.32% yearly.
The Revenue is expected to grow by 26.69% on average over the next years. This is a very strong growth
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 223.33, the valuation of VHI can be described as expensive.
Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of VHI to the average of the S&P500 Index (27.91), we can say VHI is valued expensively.
VHI is valuated quite expensively with a Price/Forward Earnings ratio of 44.65.
Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, VHI is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 223.33 | ||
| Fwd PE | 44.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 87.50% of the companies listed in the same industry.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.11 | ||
| EV/EBITDA | 42.67 |
4.3 Compensation for Growth
VHI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (7/28/2025, 7:00:00 PM)
13.4
+0.19 (+1.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.31%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap758.44M
Analysts81.54
Price Target14.99 (11.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.15%
Min EPS beat(2)-54.3%
Max EPS beat(2)-33.99%
EPS beat(4)0
Avg EPS beat(4)-61.12%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.63%
EPS beat(12)1
Avg EPS beat(12)-48.69%
EPS beat(16)2
Avg EPS beat(16)-88.33%
Revenue beat(2)2
Avg Revenue beat(2)2.65%
Min Revenue beat(2)0.61%
Max Revenue beat(2)4.69%
Revenue beat(4)3
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.69%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)2.78%
PT rev (1m)5.8%
PT rev (3m)6.38%
EPS NQ rev (1m)-17.14%
EPS NQ rev (3m)-23.28%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.59%
Revenue NQ rev (3m)1.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 223.33 | ||
| Fwd PE | 44.65 | ||
| P/S | 10.11 | ||
| P/FCF | 51.11 | ||
| P/OCF | 48.21 | ||
| P/B | 4.22 | ||
| P/tB | 15.01 | ||
| EV/EBITDA | 42.67 |
EPS(TTM)0.06
EY0.45%
EPS(NY)0.3
Fwd EY2.24%
FCF(TTM)0.26
FCFY1.96%
OCF(TTM)0.28
OCFY2.07%
SpS1.33
BVpS3.17
TBVpS0.89
PEG (NY)1.04
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROCE | 4.46% | ||
| ROIC | 3.04% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% | ||
| FCFM | 19.78% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 13.02% | ||
| Cap/Sales | 1.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 100.49% | ||
| Profit Quality | 522.09% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 | ||
| Altman-Z | 7.8 |
F-Score4
WACC9.14%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
EBIT growth 1Y21.18%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year62.54%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y308.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y293.07%
OCF growth 3YN/A
OCF growth 5YN/A